selected publications

• article

  • Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus.  Arthritis and Rheumatism.  64:2328-2337. 2012-01-01
    
  • Efficacy and safety of different doses and retreatment of rituximab: A randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)).  Annals of the Rheumatic Diseases.  69:1629-1635. 2010-01-01